| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |